Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression
Despite the evident progress in neonatal medicine, retinopathy of prematurity (ROP) remains a serious threat to the vision of premature infants, due to a still partial understanding of the mechanisms underlying the development of this disease and the lack of drugs capable of arresting its progressio...
Sábháilte in:
Príomhchruthaitheoirí: | Francesca Pascarella (Údar), Rosa Teresa Scaramuzzo (Údar), Alessandro Pini (Údar), Maurizio Cammalleri (Údar), Paola Bagnoli (Údar), Massimiliano Ciantelli (Údar), Luca Filippi (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
-
Fetal oxygenation in the last weeks of pregnancy evaluated through the umbilical cord blood gas analysis
de réir: Luca Filippi, et al.
Foilsithe / Cruthaithe: (2023) -
Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors
de réir: Luca Filippi, et al.
Foilsithe / Cruthaithe: (2022) -
The β3 adrenoceptor in proliferative retinopathies: "Cinderella" steps out of its family shadow
de réir: Maurizio Cammalleri, et al.
Foilsithe / Cruthaithe: (2023) -
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491
de réir: Isacchi Benedetta, et al.
Foilsithe / Cruthaithe: (2010) -
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
de réir: Luca Filippi, et al.
Foilsithe / Cruthaithe: (2019)